Perspectives on Cancer Therapy Development

William J.M. Hrushesky, MD, FACP, ABIM IM & MO, VIVIO Clinical Advisory Board

The Asco Post, 09/10/2023
I vividly recall a young veteran with a highly treatable and potentially curable cancer. We quickly reached what seemed a “fork in the road.” Two effective therapies were available: one inexpensive and generic and a second an equally good patented and expensive medicine. There was no evidence of superiority of either.

I informed him of the vast price difference and asked which he would prefer. This veteran did not hesitate for a second: “I will take the cheap one, doc…. I am not the only one in this foxhole.” This sentence broke my heart, and, to this day, its recall gives me goose flesh and unavoidable flowing tears. This intense and unforgettable experience, although long ago and far away, remains highly relevant to today’s cancer medicine.

Read the full article at: https://ascopost.com/issues/september-10-2023/perspectives-on-cancer-therapy-development